Led by new treatments for hepatitis C, there was an “unprecedented $20.2 billion increase in spending” for new medicines in 2014, which was triple the 2013 level, according to a <a...
VANCOUVER – Oral tofacitinib for adults with moderate to severe plaque psoriasis demonstrated sustained efficacy and a “generally manageable” safety profile throughout 2 years of follow-up in a...
ROME – Patients with systemic sclerosis have a distinct colonic microbiota, compared with healthy individuals, which could contribute to their immune dysfunction and symptoms, according to a new...
ROME – Patients with systemic sclerosis have a distinct colonic microbiota, compared with healthy individuals, which could contribute to their immune dysfunction and symptoms, according to a new...
ROME – Anti–tumor necrosis factor agents have a slight edge over conventional disease-modifying antirheumatic drugs when it comes to helping psoriatic arthritis patients who are having work issues,...
ROME – Patients with systemic sclerosis who have a range of gastointestinal symptoms and severity have higher amounts of pathogenic bacteria than do normal healthy control patients, according to Dr....
ROME – Patients with systemic sclerosis who have a range of gastointestinal symptoms and severity have higher amounts of pathogenic bacteria than do normal healthy control patients, according to Dr....
ROME – Patients with systemic sclerosis who have a range of gastointestinal symptoms and severity have higher amounts of pathogenic bacteria than do normal healthy control patients, according to Dr....
CHICAGO – Adjuvant denosumab is efficacious and safe for reducing fracture risk among women taking aromatase inhibitors (AIs) as part of their treatment for early breast cancer, finds the Austrian...
CHICAGO – Adjuvant denosumab is efficacious and safe for reducing fracture risk among women taking aromatase inhibitors (AIs) as part of their treatment for early breast cancer, finds the Austrian...